Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
JAPAN: +81-50-5539-1737
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Asia-Pacific Dermal Fillers and Botulinum Toxin MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2025

  • Purchase Options

 
In this report, the Asia-Pacific Dermal Fillers and Botulinum Toxin market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Dermal Fillers and Botulinum Toxin for these regions, from 2014 to 2025 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Dermal Fillers and Botulinum Toxin market competition by top manufacturers/players, with Dermal Fillers and Botulinum Toxin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Allergan plc.
Galderma SA
Merz Pharma GmbH & Co. KGaA
Sanofi
Anika Therapeutics, Inc.
LG Life Sciences
Suneva Medical, Inc.
Hyaltech
Speciality European Pharma
HUGEL, Inc.
Grex Pharma SaS
Daewoong Pharmaceuticals
Medy-Tox Inc.
TEOXANE Laboratories
SciVision Biotech Inc.

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Hyaluronic Acid Based Dermal Fillers
Non-hyaluronic Acid Based Dermal Fillers
Botulinum Toxin

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Dermal Fillers and Botulinum Toxin for each application, includin
Aesthetic Volume Restoration
Wrinkle Reduction

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Asia-Pacific Dermal Fillers and Botulinum Toxin Market Report 2019
1 Dermal Fillers and Botulinum Toxin Overview
1.1 Product Overview and Scope of Dermal Fillers and Botulinum Toxin
1.2 Classification of Dermal Fillers and Botulinum Toxin by Product Category
1.2.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Market Size (Sales) Comparison by Types (2014-2025)
1.2.2 Asia-Pacific Dermal Fillers and Botulinum Toxin Market Size (Sales) Market Share by Type (Product Category) in 2018
1.2.3 Hyaluronic Acid Based Dermal Fillers
1.2.4 Non-hyaluronic Acid Based Dermal Fillers
1.2.5 Botulinum Toxin
1.3 Asia-Pacific Dermal Fillers and Botulinum Toxin Market by Application/End Users
1.3.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales (Volume) and Market Share Comparison by Applications (2014-2025)
1.3.2 Aesthetic Volume Restoration
1.3.3 Wrinkle Reduction
1.4 Asia-Pacific Dermal Fillers and Botulinum Toxin Market by Region
1.4.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Market Size (Value) Comparison by Region (2014-2025)
1.4.2 China Status and Prospect (2014-2025)
1.4.3 Japan Status and Prospect (2014-2025)
1.4.4 South Korea Status and Prospect (2014-2025)
1.4.5 Taiwan Status and Prospect (2014-2025)
1.4.6 India Status and Prospect (2014-2025)
1.4.7 Southeast Asia Status and Prospect (2014-2025)
1.4.8 Australia Status and Prospect (2014-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Dermal Fillers and Botulinum Toxin (2014-2025)
1.5.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2014-2025)
1.5.2 Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2014-2025)

2 Asia-Pacific Dermal Fillers and Botulinum Toxin Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales Volume and Market Share of Key Players/Suppliers (2014-2019)
2.1.2 Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue and Share by Players/Suppliers (2014-2019)
2.2 Asia-Pacific Dermal Fillers and Botulinum Toxin (Volume and Value) by Type
2.2.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales and Market Share by Type (2014-2019)
2.2.2 Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue and Market Share by Type (2014-2019)
2.3 Asia-Pacific Dermal Fillers and Botulinum Toxin (Volume) by Application
2.4 Asia-Pacific Dermal Fillers and Botulinum Toxin (Volume and Value) by Region
2.4.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales and Market Share by Region (2014-2019)
2.4.2 Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue and Market Share by Region (2014-2019)

3 China Dermal Fillers and Botulinum Toxin (Volume, Value and Sales Price)
3.1 China Dermal Fillers and Botulinum Toxin Sales and Value (2014-2019)
3.1.1 China Dermal Fillers and Botulinum Toxin Sales Volume and Growth Rate (2014-2019)
3.1.2 China Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2014-2019)
3.1.3 China Dermal Fillers and Botulinum Toxin Sales Price Trend (2014-2019)
3.2 China Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Type
3.3 China Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Application

4 Japan Dermal Fillers and Botulinum Toxin (Volume, Value and Sales Price)
4.1 Japan Dermal Fillers and Botulinum Toxin Sales and Value (2014-2019)
4.1.1 Japan Dermal Fillers and Botulinum Toxin Sales Volume and Growth Rate (2014-2019)
4.1.2 Japan Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2014-2019)
4.1.3 Japan Dermal Fillers and Botulinum Toxin Sales Price Trend (2014-2019)
4.2 Japan Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Type
4.3 Japan Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Application

5 South Korea Dermal Fillers and Botulinum Toxin (Volume, Value and Sales Price)
5.1 South Korea Dermal Fillers and Botulinum Toxin Sales and Value (2014-2019)
5.1.1 South Korea Dermal Fillers and Botulinum Toxin Sales Volume and Growth Rate (2014-2019)
5.1.2 South Korea Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2014-2019)
5.1.3 South Korea Dermal Fillers and Botulinum Toxin Sales Price Trend (2014-2019)
5.2 South Korea Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Type
5.3 South Korea Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Application

6 Taiwan Dermal Fillers and Botulinum Toxin (Volume, Value and Sales Price)
6.1 Taiwan Dermal Fillers and Botulinum Toxin Sales and Value (2014-2019)
6.1.1 Taiwan Dermal Fillers and Botulinum Toxin Sales Volume and Growth Rate (2014-2019)
6.1.2 Taiwan Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2014-2019)
6.1.3 Taiwan Dermal Fillers and Botulinum Toxin Sales Price Trend (2014-2019)
6.2 Taiwan Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Type
6.3 Taiwan Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Application

7 India Dermal Fillers and Botulinum Toxin (Volume, Value and Sales Price)
7.1 India Dermal Fillers and Botulinum Toxin Sales and Value (2014-2019)
7.1.1 India Dermal Fillers and Botulinum Toxin Sales Volume and Growth Rate (2014-2019)
7.1.2 India Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2014-2019)
7.1.3 India Dermal Fillers and Botulinum Toxin Sales Price Trend (2014-2019)
7.2 India Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Type
7.3 India Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Application

8 Southeast Asia Dermal Fillers and Botulinum Toxin (Volume, Value and Sales Price)
8.1 Southeast Asia Dermal Fillers and Botulinum Toxin Sales and Value (2014-2019)
8.1.1 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Volume and Growth Rate (2014-2019)
8.1.2 Southeast Asia Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2014-2019)
8.1.3 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Price Trend (2014-2019)
8.2 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Type
8.3 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Application

9 Australia Dermal Fillers and Botulinum Toxin (Volume, Value and Sales Price)
9.1 Australia Dermal Fillers and Botulinum Toxin Sales and Value (2014-2019)
9.1.1 Australia Dermal Fillers and Botulinum Toxin Sales Volume and Growth Rate (2014-2019)
9.1.2 Australia Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2014-2019)
9.1.3 Australia Dermal Fillers and Botulinum Toxin Sales Price Trend (2014-2019)
9.2 Australia Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Type
9.3 Australia Dermal Fillers and Botulinum Toxin Sales Volume and Market Share by Application

10 Asia-Pacific Dermal Fillers and Botulinum Toxin Players/Suppliers Profiles and Sales Data
10.1 Allergan plc.
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Allergan plc. Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2014-2019)
10.1.4 Main Business/Business Overview
10.2 Galderma SA
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Galderma SA Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2014-2019)
10.2.4 Main Business/Business Overview
10.3 Merz Pharma GmbH & Co. KGaA
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Merz Pharma GmbH & Co. KGaA Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2014-2019)
10.3.4 Main Business/Business Overview
10.4 Sanofi
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Sanofi Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2014-2019)
10.4.4 Main Business/Business Overview
10.5 Anika Therapeutics, Inc.
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Anika Therapeutics, Inc. Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2014-2019)
10.5.4 Main Business/Business Overview
10.6 LG Life Sciences
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 LG Life Sciences Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2014-2019)
10.6.4 Main Business/Business Overview
10.7 Suneva Medical, Inc.
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Suneva Medical, Inc. Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2014-2019)
10.7.4 Main Business/Business Overview
10.8 Hyaltech
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Hyaltech Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2014-2019)
10.8.4 Main Business/Business Overview
10.9 Speciality European Pharma
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Speciality European Pharma Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2014-2019)
10.9.4 Main Business/Business Overview
10.10 HUGEL, Inc.
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 HUGEL, Inc. Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2014-2019)
10.10.4 Main Business/Business Overview
10.11 Grex Pharma SaS
10.12 Daewoong Pharmaceuticals
10.13 Medy-Tox Inc.
10.14 TEOXANE Laboratories
10.15 SciVision Biotech Inc.

11 Dermal Fillers and Botulinum Toxin Manufacturing Cost Analysis
11.1 Dermal Fillers and Botulinum Toxin Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Dermal Fillers and Botulinum Toxin

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Dermal Fillers and Botulinum Toxin Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Dermal Fillers and Botulinum Toxin Major Manufacturers in 2018
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Dermal Fillers and Botulinum Toxin Market Forecast (2019-2025)
15.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales Volume, Revenue and Price Forecast (2019-2025)
15.1.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales Volume and Growth Rate Forecast (2019-2025)
15.1.2 Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue and Growth Rate Forecast (2019-2025)
15.1.3 Asia-Pacific Dermal Fillers and Botulinum Toxin Price and Trend Forecast (2019-2025)
15.2 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales Volume, Revenue and Growth Rate Forecast by Region (2019-2025)
15.2.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales Volume and Growth Rate Forecast by Region (2019-2025)
15.2.2 Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue and Growth Rate Forecast by Region (2019-2025)
15.2.3 China Dermal Fillers and Botulinum Toxin Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.4 Japan Dermal Fillers and Botulinum Toxin Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.5 South Korea Dermal Fillers and Botulinum Toxin Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.6 Taiwan Dermal Fillers and Botulinum Toxin Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.7 India Dermal Fillers and Botulinum Toxin Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.8 Southeast Asia Dermal Fillers and Botulinum Toxin Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.9 Australia Dermal Fillers and Botulinum Toxin Sales, Revenue and Growth Rate Forecast (2019-2025)
15.3 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales, Revenue and Price Forecast by Type (2019-2025)
15.3.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales Forecast by Type (2019-2025)
15.3.2 Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue Forecast by Type (2019-2025)
15.3.3 Asia-Pacific Dermal Fillers and Botulinum Toxin Price Forecast by Type (2019-2025)
15.4 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales Forecast by Application (2019-2025)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer


 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us